Hepatitis C
391 results
1 - 100
Hepatitis C- MICROBIOLOGY
- CLINICAL
- SITES OF INFECTION
- TREATMENT
- General comments
- Treatment-naive
- Treatment failures
- HIV/HCV co-infection
- Cirrhotic patients
- Chronic kidney disease patients
- Regimens NOT recommended
- Follow-up
- Experimental and Future HCV Treatment Options
- Prevention
- OTHER INFORMATION
- Basis for recommendation
- References
- Hepatitis Due to Infections other than Hepatitis A, B, C, D, or E
Viral Hepatitis- Ribavirin
- Daclatasvir
- Simeprevir
- Oteseconazole
- Chronic Hepatitis
- Hepatitis B (HBV) vaccines
- Cobicistat
- Oritavancin
- Sofosbuvir + Ledipasvir
- Hepatitis A
- Viekira Pak
- Glecaprevir + Pibrentasvir
- Sofosbuvir + velpatasvir
- Interferon alpha (ABX)
INTERFERONS, ALPHA- Nirmatrelvir/Ritonavir
- Gepotidacin
- Technivie
- Tipranavir
- Nevirapine
- Hepatitis A vaccine (HAV)
- lubiprostone
- Anidulafungin
- Dalbavancin
- Eravacycline
- Quinine
- Tigecycline
- daclatasvir
- Elbasvir/Grazoprevir
- Nelfinavir
- elbasvir/grazoprevir
- Bictegravir
- Sofosbuvir
- Fluconazole
- Bedaquiline
- Delstrigo
- Doravirine
- peginterferon alfa-2a
- Isavuconazonium sulfate
- Telithromycin
- Staging Liver Disease
- ombitasvir/paritaprevir/ritonavir
- ombitasvir/paritaprevir/ritonavir/dasabuvir
- interferon alpha-2b
- Hepatitis D
- Letermovir
- ezetimibe
- abacavir/dolutegravir/lamivudine
- interferon alfacon-1